<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">352506</id>
  <title nil="true"/>
  <common-name>(1r,2r,4r,5r,7s,10r,11s,14r,15r,18s)-4-ethoxy-1,2,10,15,19,19-hexamethyl-7-propan-2-yl-6-oxahexacyclo[12.8.0.02,11.05,7.05,10.015,20]docosan-18-ol</common-name>
  <description>(1r,2r,4r,5r,7s,10r,11s,14r,15r,18s)-4-ethoxy-1,2,10,15,19,19-hexamethyl-7-propan-2-yl-6-oxahexacyclo[12.8.0.02,11.05,7.05,10.015,20]docosan-18-ol is a chemical compound with the formula C32H54O3. It has an average molecular weight of 486.80 g/mol.</description>
  <cas nil="true"/>
  <pubchem-id>42608296</pubchem-id>
  <chemical-formula>C32H54O3</chemical-formula>
  <weight>486.8</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T18:53:03Z</created-at>
  <updated-at type="dateTime">2026-08-31T18:53:03Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CCOC1CC2(C(CCC3C2(CCC4C3(CCC(C4(C)C)O)C)C)C5(C16C(O6)(CC5)C(C)C)C)C</moldb-smiles>
  <moldb-formula>C32H54O3</moldb-formula>
  <moldb-inchi>InChI=1S/C32H54O3/c1-10-34-25-19-30(9)23(29(8)17-18-31(20(2)3)32(25,29)35-31)12-11-22-27(6)15-14-24(33)26(4,5)21(27)13-16-28(22,30)7/h20-25,33H,10-19H2,1-9H3/t21?,22-,23-,24+,25-,27+,28-,29-,30-,31+,32+/m1/s1</moldb-inchi>
  <moldb-inchikey>VXGFTFVZVXNHMW-YXSZZDAOSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">486.4072956</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM348399</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>(1r,2r,4r,5r,7s,10r,11s,14r,15r,18s)-4-ethoxy-1,2,10,15,19,19-hexamethyl-7-propan-2-yl-6-oxahexacyclo[12.8.0.02,11.05,7.05,10.015,20]docosan-18-ol</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Lipids and lipid-like molecules</superklass>
  <klass>Prenol lipids</klass>
  <subklass>Hopanoids</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0302794</sync-id>
  <structure-inchikey>VXGFTFVZVXNHMW-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40000000000000002000800000000000001002000001000000000000000000400410001002000200000000000000800000000000000004000000000200000000000100000410000000000000200001000000800001000100008000000000008000000000010001000000000000000040008000020000000000000000000000100000000148000000100000000004000000200000000000000000020000400020000000000004000000000000000000000000000800000020040000000000000000408000000000000000000000000000000000000000000020000000000004000000080000000000000000000000401000000001000000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAKAAAAIABBgBgAAAAAQMGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:50:15Z</structure-indexed-at>
</compound>
